Literature DB >> 28641911

Image Fusion of Real-Time Ultrasonography with Computed Tomography: Factors Affecting the Registration Error and Motion of Focal Hepatic Lesions.

Min Woo Lee1, Hyun Jeong Park2, Tae Wook Kang1, Jiwon Ryu3, Won-Chul Bang3, Bora Lee4, Eun Sun Lee5, Byung Ihn Choi5.   

Abstract

Factors affecting the registration error (RE) and motion of focal hepatic lesions (FHLs) in image fusion of real-time ultrasonography (US) with computed tomography (CT) images were prospectively assessed by focusing on respiratory movement and FHL location. Real-time US and pre-acquired CT images at end-inspiration were fused with FHLs for 103 patients. Three-dimensional US data containing FHLs were obtained during end-inspiratory/expiratory phases. Multivariate analysis revealed that diaphragm motion (p < 0.001), chronic liver disease (p = 0.02) and the absolute difference in distance between the FHL and the central portal vein (CPV) during respiration (p = 0.03) were the independent factors that revealed the maximum effect on RE. In contrast, diaphragm motion (p < 0.001) and distance between the FHL and CPV at inspiration (p = 0.036) revealed the maximum effect on FHL motion. In conclusion, RE and FHL motion are affected by the degree of respiratory movement and the location of the FHL. Therefore, image fusion with CT images should be used with caution if the degree of respiratory motion is significant or if the FHL is located at the periphery of the liver.
Copyright © 2017 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography; Fusion imaging; Liver; Real-time ultrasonography; Registration error; Respiration

Mesh:

Year:  2017        PMID: 28641911     DOI: 10.1016/j.ultrasmedbio.2017.01.027

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  6 in total

1.  Mixed reality navigation system for ultrasound-guided percutaneous punctures: a pre-clinical evaluation.

Authors:  Carlos F Davrieux; Mariano E Giménez; Cristians A González; Alexandre Ancel; Maxime Guinin; Bénédicte Fahrer; Edgardo Serra; Jung-Myun Kwak; Jacques Marescaux; Alexandre Hostettler
Journal:  Surg Endosc       Date:  2019-03-25       Impact factor: 4.584

2.  Utility of Real-time CT/MRI-US Automatic Fusion System Based on Vascular Matching in Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: A Prospective Study.

Authors:  Seungchul Han; Jeong Min Lee; Dong Ho Lee; Jeong Hee Yoon; Won Chang
Journal:  Cardiovasc Intervent Radiol       Date:  2021-07-26       Impact factor: 2.740

3.  Usefulness of Virtual Expiratory CT Images to Compensate for Respiratory Liver Motion in Ultrasound/CT Image Fusion: A Prospective Study in Patients with Focal Hepatic Lesions.

Authors:  Tae Wook Kang; Min Woo Lee; Dong Ik Cha; Hyun Jung Park; Jun Sung Park; Won Chul Bang; Seon Woo Kim
Journal:  Korean J Radiol       Date:  2019-02       Impact factor: 3.500

4.  Manual versus automated image fusion of real-time ultrasonography and MR/CT images for radiofrequency ablation of hepatic tumors: results of a randomized prospective trial (NCT02705118).

Authors:  Moon Hyung Choi; Joon-Il Choi; Young Joon Lee
Journal:  Ultrasonography       Date:  2020-05-21

5.  Augmented reality for interventional oncology: proof-of-concept study of a novel high-end guidance system platform.

Authors:  Marco Solbiati; Katia M Passera; Alessandro Rotilio; Francesco Oliva; Ilaria Marre; S Nahum Goldberg; Tiziana Ierace; Luigi Solbiati
Journal:  Eur Radiol Exp       Date:  2018-07-31

6.  Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography.

Authors:  Min Woo Lee; Hyo Keun Lim; Hyunchul Rhim; Dong Ik Cha; Tae Wook Kang; Kyoung Doo Song; Ji Hye Min; Geum-Youn Gwak; Seonwoo Kim; David S K Lu
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.